The burden of cardiovascular disease risk factors: A current problem

Andrzej Pająk1, Piotr Jankowski2,3, Tomasz Zdrojewski4

  • 1Department of Epidemiology and Population Studies, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland. andrzej.pajak@uj.edu.pl.

Kardiologia Polska
|February 9, 2022
PubMed

Insights

The COVID-19 pandemic exacerbated cardiovascular disease (CVD) deaths in Poland. Pre-existing CVD risk factors, like obesity and diabetes, increased severe COVID-19 outcomes and mortality.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • The COVID-19 pandemic significantly increased all-cause and cardiovascular disease (CVD) mortality in Poland.
  • Attention to CVD prevention waned during the pandemic, despite emerging links between COVID-19 severity and CVD risk factors.

Purpose of the Study:

  • To review the prevalence of CVD risk factors in the Polish adult population.
  • To discuss the association between CVD risk factors and COVID-19 outcomes.

Main Methods:

  • Literature review of existing evidence.
  • Analysis of reports on COVID-19 patient characteristics and outcomes.
  • Examination of CVD risk factor prevalence in Poland.

Main Results:

  • CVD and its risk factors, particularly obesity and diabetes, are linked to severe or fatal COVID-19.
  • High prevalence of these risk factors may heighten COVID-19 susceptibility and complication risk in Poland.
  • Increased CVD deaths during the pandemic are likely multifactorial, including direct cardiac complications and reduced healthcare access.

Conclusions:

  • The high burden of CVD risk factors in Poland poses a significant vulnerability during pandemics like COVID-19.
  • Addressing CVD risk factors is crucial for mitigating severe COVID-19 outcomes and overall cardiovascular mortality.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
234
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
172
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
496
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
58
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.7K